Open AccessCost-effectiveness of olaparib, a PARP inhibitor, for patients with metastatic castration-resistant prostate cancer in China and United States
Author(s) -
Chenxia Xu,
Jiaqin Cai,
Jie Zhuang,
Bin Zheng,
Li Chen,
Hong Sun,
Guiyan Zheng,
Xiaoxia Wei,
Maobai Liu
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-3637
Subject(s) - olaparib , medicine , enzalutamide , prostate cancer , oncology , markov model , parp inhibitor , cancer , markov chain , computer science , androgen receptor , machine learning , poly adp ribose polymerase , gene , polymerase , chemistry , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom